CLASS II Device recall · Reported 21 Feb 2018 · FDA Enforcement Report

Xpert CT/NG recalled by Cepheid

Cepheid is recalling Xpert CT/NG, distributed in Puerto Rico. The recall was initiated on 9 Oct 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: 25718, 25719, 25725, and 25727.
Quantity recalled3,586 kits (49,400 units)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0592-2018
FDA event ID
78910
Recalling firm
Cepheid, Sunnyvale, CA
Classification
Class II
Status
Terminated
Recall initiated
9 Oct 2017
FDA classified
12 Feb 2018
Reported
21 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

9 Oct 2017Recall initiated by company
12 Feb 2018Classified by FDA+126 days
21 Feb 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Xpert CT/NG Catalog GXCT/NG-120 Batch 1000049568, Catalog GXCT/NG-10 Batch 1000053075, Catalog GXCT/NG-10 Batch 1000056156 and Catalog GXCT/NG-10 Batch 1000056157. Is a qualitative in vitro real-time PCR test.

Where it was distributed

Worldwide Distribution -- USA, Puerto Rico, and Haiti.

Puerto Rico

Questions about this recall

Why was it recalled?

Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.

Which lots are affected?

Lot numbers: 25718, 25719, 25725, and 25727.

Where was it sold?

Worldwide Distribution -- USA, Puerto Rico, and Haiti.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cepheid

All 12

Other Test Kits & Diagnostics recalls

All 2,663